Davis Jerel is Director of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 447,013 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Davis Jerel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Sale (or disposition) back to the issuer
-
447,013 Reduced 100.0%
0 Common Stock
May 26 2023
BUY
Exercise of conversion of derivative security
-
3,300 Added 0.45%
733,770 Common Stock
Apr 17 2023
SELL
Open market or private sale
$6,138,016 $20.75 p/Share
295,808 Reduced 40.0%
443,713 Common Stock
Dec 22 2022
BUY
Other acquisition or disposition
-
1,646 Added 0.22%
739,521 Common Stock
Sep 12 2022
BUY
Other acquisition or disposition
-
3,291 Added 0.44%
737,875 Common Stock
Aug 12 2022
BUY
Other acquisition or disposition
-
1,646 Added 0.22%
734,584 Common Stock
Apr 04 2022
BUY
Other acquisition or disposition
-
2,468 Added 0.34%
732,938 Common Stock
Oct 05 2020
BUY
Grant, award, or other acquisition
-
730,470 Added 50.0%
730,470 Common Stock

Also insider at

RPTX
Repare Therapeutics Inc. Healthcare
GRPH
Graphite Bio, Inc. Healthcare
TSBX
Turnstone Biologics Corp.
DJ

Davis Jerel

Director
Seattle, WA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Track Activities on KDNY